ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

ClinicalTrials.gov ID: NCT03478930

Public ClinicalTrials.gov record NCT03478930. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 3, 2026, 8:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label Extension Study of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps

Study identification

NCT ID
NCT03478930
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
249 participants

Conditions and interventions

Interventions

  • Omalizumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2018
Primary completion
Mar 15, 2020
Completion
Mar 15, 2020
Last update posted
Apr 3, 2022

2018 – 2020

United States locations

U.S. sites
25
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
Clinical Research Center of Alabama, LLC Birmingham Alabama 35209
Banner University of Arizona Medical Center Tucson Arizona 85724
Jonathan Corren MD, Inc. Los Angeles California 90025
The Allergy Station at Sacramento ENT Roseville California 95661
Bensch Clinical Research LLC Stockton California 95207
Colorado ENT & Allergy Colorado Springs Colorado 80909
Specialist Global Research Hialeah Florida 33012
Vitae Research Center Miami Florida 33135
University of South Florida Tampa Florida 33613
Asthma & Allergy of Idaho Twin Falls Idaho 83301
University of Kansas Medical Center Kansas City Kansas 66160
Tandem Clinical Research, LLC Marrero Louisiana 70072
Chesapeake Clinical Research Inc - CRN Baltimore Maryland 21236
Institute for Asthma & Allergy Chevy Chase Maryland 20815
Brigham and Womens Hospital Boston Massachusetts 02115
University of Missouri Health Care System Columbia Missouri 65212
Northwell Health Great Neck New York 11021
Montefiore Medical Center The Bronx New York 10461
Vital Prospects Clinical Research Institute PC - CRN Tulsa Oklahoma 74136
Allergy Associates Research Center LLC - CRN Portland Oregon 97202
Medical University of South Carolina Hospital Charleston South Carolina 29425
TTS Research Boerne Texas 78006
Allergy & Asthma Res Ctr PA San Antonio Texas 78251
Chrysalis Clinical Research St. George Utah 84790
Eastern Virginia Medical School Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03478930, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2022 · Synced May 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03478930 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →